Regeneron upgraded to Outperform from Neutral at RW Baird
RW Baird upgraded Regeneron citing a stronger than expected uptake for Eylea after the company pre-announced Q4 Eylea revenue of $24-25M. The firm raised its price target for shares to $81 from $56. :theflyonthewall.com
News For REGN From The Last 14 Days
Check below for free stories on REGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
